University of Miami Sylvester Comprehensive Cancer Center

 

CML and MPNs: Final Frontiers and New Breakthroughs
21:24

University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benefit to Ruxolitinib for Patients With CSF3R Mutation?

FEATURING Jeffrey Tyner
  • 30 views
  • October 27, 2020
26:24

University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on CML: What Strategies Can Help Overcome Multi-TKI Resistance or Intolerance?

FEATURING Jorge Cortés
  • 144 views
  • October 23, 2020
  • 1
25:18

University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Ph- MPN: What Are the Potential Benefits and Limitations to JAKi? Which Alternative Pathogenetic Mechanisms Can Improve Therapeutic Benefit?

FEATURING Olatoyosi Odenike
  • 156 views
  • October 23, 2020
  • 1
21:19

University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on BPDCN: Efficacy Analysis of Available Standard Therapies and Novel Therapies in Development

FEATURING Naveen Pemmaraju
  • 13 views
  • October 23, 2020